Cargando…

Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice

Background and objectives: The efficacy and safety of ustekinumab have been proved in clinical trials. In daily clinical practice, knowing the factors that determine survival differences of biological drugs allows psoriasis treatment to be optimized as a function of patient characteristics. The main...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galache Osuna, Cristina, Gómez-Vila, Borja, Aubán Pariente, Javier, Vázquez Losada, Beatriz, Gómez de Castro, Celia, Requena López, Sheila, de Dios Velázquez, Álvaro, Palacios García, Laura, Ordoñez Fernández, Lucía, Gómez Diez, Santiago, Vázquez López, Francisco, Santos-Juanes, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693782/ https://www.ncbi.nlm.nih.gov/pubmed/33143166 http://dx.doi.org/10.3390/medicina56110584

Ejemplares similares

Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib
por: Aubán-Pariente, Javier, et al.
Publicado: (2021)

Red Plaque on the Dorsal Hand With Necrosis: Think Before You Amputate
por: Mir-Bonafé, Marc, et al.
Publicado: (2020)

Use of Biological Treatments in Elderly Patients with Skin Psoriasis in the Real World
por: Osuna, Cristina Galache, et al.
Publicado: (2021)

Ustekinumab: differential use in psoriasis
por: Uhlenhake, Elizabeth E, et al.
Publicado: (2011)

Trigeminal trophic syndrome simulating rodent ulcer basal cell carcinoma: a new clinico-dermoscopic approach
por: de Castro, Celia Gómez, et al.
Publicado: (2017)

Cutaneous and Mucosal Manifestations Associated with Celiac Disease
por: Rodrigo, Luis, et al.
Publicado: (2018)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
por: Olabi, Bayanne, et al.
Publicado: (2020)

Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
por: Elberdín, Laida, et al.
Publicado: (2022)

Paradoxical Flare of Psoriasis after Ustekinumab Therapy
por: Lee, Ho Yeol, et al.
Publicado: (2017)

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
por: Lynch, Maeve, et al.
Publicado: (2017)

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis
por: Tsakok, Teresa, et al.
Publicado: (2019)

Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis
por: García-García, B., et al.
Publicado: (2020)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Mercuri, Santo Raffaele, et al.
Publicado: (2010)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009)

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab
por: Husein-ElAhmed, Husein, et al.
Publicado: (2013)

Genome-Wide Association Study of Ustekinumab Response in Psoriasis
por: Connell, William T., et al.
Publicado: (2022)

Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations
por: Yang, Seungkeol, et al.
Publicado: (2021)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology()
por: Steglich, Raquel Bissacotti, et al.
Publicado: (2014)

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
por: Krulig, Eliana, et al.
Publicado: (2010)

Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
por: Hermanns-Lê, Trinh, et al.
Publicado: (2012)

Influence of ustekinumab on body weight of patients with psoriasis: an initial report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2014)

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases
por: Kim, Ye Seul, et al.
Publicado: (2016)

Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
por: Tonini, Annalisa, et al.
Publicado: (2019)

Listeria Meningitis in a Patient With Plaque Psoriasis on Ustekinumab Therapy
por: Roy, Moni, et al.
Publicado: (2022)

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
por: Avgerinou, Georgia, et al.
Publicado: (2012)

Recapturing adequate control of psoriasis by additional immunosuppressive agents alongside ustekinumab
por: Jayasekera, Prativa S., et al.
Publicado: (2016)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Okita, Aline Lissa, et al.
Publicado: (2020)

Plaque psoriasis and morphea in a patient on ustekinumab: A case report
por: Cirone, Katrina, et al.
Publicado: (2023)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
por: Chan, Wai Sze Agnes, et al.
Publicado: (2022)

Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
por: Garcia-Valladares, Ignacio, et al.
Publicado: (2011)

Ustekinumab Biotherapy and Real-Time Psoriasis Capacitance Mapping: A Pilot Study
por: Piérard-Franchimont, Claudine, et al.
Publicado: (2012)

Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis
por: Kapoor, Shailendra
Publicado: (2012)

Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab
por: Zhao, Yue, et al.
Publicado: (2014)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
por: Elkady, Amal, et al.
Publicado: (2017)

Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
por: Hsiao, Chuan-Yu, et al.
Publicado: (2017)

Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
por: Petty, Amy J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g80nf7frod5e9dvfe3ug5e9kku